Patents Assigned to University of Utah Research Foundation, a Utah corporation
  • Publication number: 20030036208
    Abstract: The present invention relates to a method for screening drugs for use in treating hypertension using the tubular renin-angiotensinogen system identified by the present invention. The invention further relates to a method to diagnose sodium status and sensitivity in an individual by measuring urinary angiotensinogen or angiotensin-I.
    Type: Application
    Filed: October 16, 2002
    Publication date: February 20, 2003
    Applicant: University of Utah Research Foundation, a Utah corporation
    Inventors: Andreas Rohrwasser, Terry Morgan, Jean-Marc Lalouel